A new report on the Tissue Diagnostics Market research study, published by Reports and Data, provides an in-depth survey of the dominant participants of the industry –the basis points for which are the financial highlights, company outline, SWOT Analysis, Product Portfolio, as well as major strategies and the expansion plans of the new and potential contenders. This report is also anticipated to reflect consistent growth in the coming years since consumers are now more aware of product quality. This market analysis of an industry is a crucial factor that numerous stakeholders, such as investors, traders, suppliers, and others, will find beneficial.
The growing prevalence of cancer is a significant factor in driving the market growth. Cancer has a significant impact on global society, including the US. Detection of cancer at an early stage significantly increases the chances 0f survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection of cancer. Identifying likely warning symptoms of cancer and taking rapid measures is necessary for early diagnosis. Greater awareness of probable symptoms of cancer amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the survival rate and hence would be instrumental in increasing the market demand.
COVID-19 Impact
As the global economies are experiencing the negative impact of the Covid-19 pandemic, organizations are suffering losses, among various other challenges. Nevertheless, firms in the pharmaceutical industry are of immense importance in combatting the pandemic and are witnessing positive growth in the contagious disease landscape with the race for treatment approval therapy gaining momentum. Tissue diagnostics finds usage in detecting the presence of SARS-CoV-2 in the tissues of patients and hence is garnering significant momentum in the market.
Get a Free Sample now@ https://www.reportsanddata.com/sample-enquiry-form/3411
Further key findings from the report suggest
- By type, diagnostics kits held a substantial market share in 2019, owing to the offering of ease and convenience of use. There are various diagnostic kits available in the market, some of which provide an instant result, whereas others as collection devices for tissue specimens, which need to be sent to laboratories for further processing.
- By technology, in situ hybridization held the second-largest market share in 2019. There are many advantages of in situ hybridization comprising the application to frozen tissues, as well as its usage in combination with immunohistochemistry for the identification protein, along with mRNA.
- By application, prostate cancer is likely to grow at a rate of 5.9% in the forecast period. According to the American Cancer Society, men aged 65 years or older have around 66.0% higher risk of suffering from the disease. Also, prostate cancer holds the second spot among the cancer diseases responsible for the death of men in America.
- By end-user, the pharmaceutical organization is likely to grow at a rate of 6.5% in the forecast period 2019, owing to an extensive application of tissue diagnostic in the process of drug development and several other analytical procedures.
- The market in the Asia Pacific region is expected to grow at the fastest rate of 7.3% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.
- Key participants include Thermo Fisher Scientific, Danaher, Becton, Dickinson, and Company, Agilent Technologies, Abbott, Roche, Merck KGaA, Biogenex, Hologic Inc., and Abcam, among others.
- In May 2020, Agilent Technologies Inc. Visiopharm made an announcement about the signing of a co-agreement for end-to-end standardization and quality of tissue diagnostics and cater to the growing requirements of pathology labs globally.
Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/3411
For the purpose of this report, Reports and Data have segmented the global tissue diagnostics market on the basis of type, technology, application, end-user, and region:
Type Outlook (Revenue, USD Million; 2017-2027)
- Diagnostic Kits
- Antibodies
- Slide Training System
- Tissue Processing System
Technology Outlook (Revenue, USD Million; 2017-2027)
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology & Workflow
- Primary & Special Training
- Anatomic Pathology
Application Outlook (Revenue, USD Million; 2017-2027)
- Breast Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Lung Cancer
- Others
End-User Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Laboratories
- Pharmaceutical Organizations
- Contract Research Organizations
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- MEA
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/tissue-diagnostics-market
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
